CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2

The literature virtually lacks the results of investigations aimed to study the clinical picture of ankylosing spondylitis (AS) in the real practice of rheumatologists  in Russia. At the same time, these investigations may give information  on not only the epidemiological aspects of the disease, but...

Full description

Bibliographic Details
Main Authors: Sh. F. Erdes, T. V. Dubinina, D. E. Abdulganieva, I. B. Vinogradova, L. P. Evstigneeva, A. V. Elonakov, E. N. Otteva, T. A. Raskina, T. S. Salnikova, R. R. Samigullina, V. N. Sorotskaya, L. M. Shkil
Format: Article
Language:Russian
Published: IMA PRESS LLC 2016-09-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2245
_version_ 1797862713930547200
author Sh. F. Erdes
T. V. Dubinina
D. E. Abdulganieva
I. B. Vinogradova
L. P. Evstigneeva
A. V. Elonakov
E. N. Otteva
T. A. Raskina
T. S. Salnikova
R. R. Samigullina
V. N. Sorotskaya
L. M. Shkil
author_facet Sh. F. Erdes
T. V. Dubinina
D. E. Abdulganieva
I. B. Vinogradova
L. P. Evstigneeva
A. V. Elonakov
E. N. Otteva
T. A. Raskina
T. S. Salnikova
R. R. Samigullina
V. N. Sorotskaya
L. M. Shkil
author_sort Sh. F. Erdes
collection DOAJ
description The literature virtually lacks the results of investigations aimed to study the clinical picture of ankylosing spondylitis (AS) in the real practice of rheumatologists  in Russia. At the same time, these investigations may give information  on not only the epidemiological aspects of the disease, but also a variety of its clinical presentation, its social importance, allow evaluation of the efficiency of therapy, and plan a system of further health care costs.Subjects and methods. In early 2015, the cross-sectional multicenter  non-interventional trial EPICA2 was conducted to refine the clinical picture of AS in the real practice of a rheumatologist. The trial involved 402 patients with AS from 10 centers of Russia. The patients were examined using the international standards accepted for this disease. Results and discussion. 180 out of the 402 patients were treated in hospital; the others were examined during outpatient visits. The patients' mean age was 40.8±11.5 years; there were 292 (72.6%) men; 82.6% were HLA-B27 positive. The average age of onset was 27.6 years; the interval between symptom onset and diagnosis was 85.2 months. The rheumatologists  established the diagnosis in 87.3% of the cases. BASDAI and BASFI averaged 4.3±2.1 and 4.1±1.8, respectively. At the trial, there was peripheral arthritis in 33.1% of the patients, enthesitis in 37.1%, and dactylitis in 1.2%. Joint endoprosthesis was carried out in 4.7% of the patients. The most common  comorbidities were hypertension (25.1%), gastric ulcer (9.7%), coronary heart disease (4.0%), and diabetes mellitus (3.0%).Conclusion. AS is diagnosed in real practice more than 7 years after its onset mainly by rheumatologists.The delay of the diagnosis is mostly associated with the fact that specialists of other medical specialties are unaware of the clinical presentation  of the disease. The examined group of patients with AS shows a relatively high activity and obvious functional impairments, which is primarily related to the specific features of patient selection in this trial.
first_indexed 2024-04-09T22:23:56Z
format Article
id doaj.art-53988aa5113e453e9a6d0818d18e31dc
institution Directory Open Access Journal
issn 1995-4484
1995-4492
language Russian
last_indexed 2024-04-09T22:23:56Z
publishDate 2016-09-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj.art-53988aa5113e453e9a6d0818d18e31dc2023-03-22T13:45:51ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922016-09-01541S101410.14412/1995-4484-2016-1S-10-142113CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2Sh. F. Erdes0T. V. Dubinina1D. E. Abdulganieva2I. B. Vinogradova3L. P. Evstigneeva4A. V. Elonakov5E. N. Otteva6T. A. Raskina7T. S. Salnikova8R. R. Samigullina9V. N. Sorotskaya10L. M. Shkil11V.A. Nasonova Research Institute of Rheumatology, MoscowKazan State Medical University, Ministry of Health of Russia, KazanV.A. Nasonova Research Institute of Rheumatology, MoscowRegional Clinical Hospital One, UlyanovskRegional Rheumatology Center, Sverdlovsk Regional Clinical Hospital One, YekaterinburgM.F. Vladimirsky Moscow Regional Clinical Research Institute, MoscowProfessor S.I. Sergeev Territorial Clinical Hospital One, KhabarovskRegional Clinical Hospital for War Veterans, KemerovoRegional Clinical Hospital, TulaI.I. Mechnikov NorthWestern State Medical University, Ministry of Health of Russia, Saint PetersburgRegional Clinical Hospital, TulaI.S. Berzon City Clinical Hospital Twenty, KrasnoyarskThe literature virtually lacks the results of investigations aimed to study the clinical picture of ankylosing spondylitis (AS) in the real practice of rheumatologists  in Russia. At the same time, these investigations may give information  on not only the epidemiological aspects of the disease, but also a variety of its clinical presentation, its social importance, allow evaluation of the efficiency of therapy, and plan a system of further health care costs.Subjects and methods. In early 2015, the cross-sectional multicenter  non-interventional trial EPICA2 was conducted to refine the clinical picture of AS in the real practice of a rheumatologist. The trial involved 402 patients with AS from 10 centers of Russia. The patients were examined using the international standards accepted for this disease. Results and discussion. 180 out of the 402 patients were treated in hospital; the others were examined during outpatient visits. The patients' mean age was 40.8±11.5 years; there were 292 (72.6%) men; 82.6% were HLA-B27 positive. The average age of onset was 27.6 years; the interval between symptom onset and diagnosis was 85.2 months. The rheumatologists  established the diagnosis in 87.3% of the cases. BASDAI and BASFI averaged 4.3±2.1 and 4.1±1.8, respectively. At the trial, there was peripheral arthritis in 33.1% of the patients, enthesitis in 37.1%, and dactylitis in 1.2%. Joint endoprosthesis was carried out in 4.7% of the patients. The most common  comorbidities were hypertension (25.1%), gastric ulcer (9.7%), coronary heart disease (4.0%), and diabetes mellitus (3.0%).Conclusion. AS is diagnosed in real practice more than 7 years after its onset mainly by rheumatologists.The delay of the diagnosis is mostly associated with the fact that specialists of other medical specialties are unaware of the clinical presentation  of the disease. The examined group of patients with AS shows a relatively high activity and obvious functional impairments, which is primarily related to the specific features of patient selection in this trial.https://rsp.mediar-press.net/rsp/article/view/2245ankylosing spondylitisepica trialsepica2 trialmulticenter trial
spellingShingle Sh. F. Erdes
T. V. Dubinina
D. E. Abdulganieva
I. B. Vinogradova
L. P. Evstigneeva
A. V. Elonakov
E. N. Otteva
T. A. Raskina
T. S. Salnikova
R. R. Samigullina
V. N. Sorotskaya
L. M. Shkil
CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2
Научно-практическая ревматология
ankylosing spondylitis
epica trials
epica2 trial
multicenter trial
title CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2
title_full CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2
title_fullStr CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2
title_full_unstemmed CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2
title_short CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2
title_sort clinical characteristics of ankylosing spondylitis in real practice in russia results of the cross sectional non interventional trial epica2
topic ankylosing spondylitis
epica trials
epica2 trial
multicenter trial
url https://rsp.mediar-press.net/rsp/article/view/2245
work_keys_str_mv AT shferdes clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT tvdubinina clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT deabdulganieva clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT ibvinogradova clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT lpevstigneeva clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT avelonakov clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT enotteva clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT taraskina clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT tssalnikova clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT rrsamigullina clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT vnsorotskaya clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2
AT lmshkil clinicalcharacteristicsofankylosingspondylitisinrealpracticeinrussiaresultsofthecrosssectionalnoninterventionaltrialepica2